Trichomonas vaginalis Among Cisgender Women Taking Doxycycline Postexposure Prophylaxis
Authors:
- Lauren R VioletteLVLauren R Violette
- Deborah DonnellDDDeborah Donnell
- Josephine B OdoyoJOJosephine B Odoyo
- Victor OmolloVOVictor Omollo
- Felix O MogakaFMFelix O Mogaka
- R Scott McClellandRMR Scott McClelland
- Jennifer E BalkusJBJennifer E Balkus
- Elizabeth A BukusiEBElizabeth A Bukusi
- Jared M BaetenJBJared M Baeten
- Jenell StewartJSJenell Stewart
- 9 October 2025
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 233 (2) , 411-415
Abstract
Doxycycline treats and prevents several bacterial and parasitic infections and has been proposed as a possible treatment for Trichomonas vaginalis. Nested in a trial of doxycycline postexposure prophylaxis among cisgender women in Kenya, we conducted a secondary analysis of incident T. vaginalis infections. Among 224 cisgender women randomized to doxycycline postexposure prophylaxis and 225 to standard-of-care, there were 27 T. vaginalis diagnoses in the doxycycline postexposure prophylaxis group and 29 in the standard-of-care group (RR: 0.96, 95% CI: 0.54–1.73, P = .9). Understanding doxycycline postexposure prophylaxis's impact on T. vaginalis remains an important public health question that warrants further investigation.Keywords
Funding Information
- NIH (R01AI145971)
- NIH (K23MH124466)
- NIH (P30AI027757)
This publication has 12 references indexed in Scilit:
- Doxycycline Prophylaxis to Prevent Sexually Transmitted Infections in WomenNew England Journal of Medicine, 2023
- Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted InfectionsNew England Journal of Medicine, 2023
- Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis: study protocol for an open-label randomized trialTrials, 2022
- Clearance of Mycoplasma genitalium and Trichomonas vaginalis Among Adolescents and Young Adults With Pelvic Inflammatory Disease: Results From the Tech-N StudySexually Transmitted Diseases, 2020
- Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trialThe Lancet Infectious Diseases, 2018
- A Review of Evidence-Based Care of Symptomatic Trichomoniasis and AsymptomaticTrichomonas vaginalisInfectionsClinical Infectious Diseases, 2015
- Novel Insights into the Molecular Events Linking to Cell Death Induced by Tetracycline in the Amitochondriate Protozoan Trichomonas vaginalisAntimicrobial Agents and Chemotherapy, 2015
- Treatment of Metronidazole-Resistant Trichomonas vaginalis With TinidazoleSexually Transmitted Diseases, 2004
- In Vitro Metronidazole and Tinidazole Activities against Metronidazole- Resistant Strains of Trichomonas vaginalisAntimicrobial Agents and Chemotherapy, 2003
- Trichomonas vaginalis and amplification of HIV-1 transmissionThe Lancet, 1998